Rika Kihara

490 total citations
12 papers, 86 citations indexed

About

Rika Kihara is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Rika Kihara has authored 12 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Rika Kihara's work include Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Rika Kihara is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Rika Kihara collaborates with scholars based in Japan and United States. Rika Kihara's co-authors include Kensei Tobinai, Naokuni Uike, Shin Fujisawa, Takahiro Yamauchi, Takashi Watanabe, Tomomitsu Hotta, Toshiya Yokozawa, Kosuke Tsuboi, Kiyoshi Ando and Toru Sakura and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Rika Kihara

8 papers receiving 85 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rika Kihara Japan 5 39 38 33 33 12 12 86
Ellen Fraint United States 5 44 1.1× 16 0.4× 19 0.6× 11 0.3× 11 0.9× 13 89
Chengqing Wu United States 7 46 1.2× 25 0.7× 46 1.4× 9 0.3× 23 1.9× 16 102
Ramona Crescenzo United States 4 80 2.1× 16 0.4× 52 1.6× 12 0.4× 10 0.8× 5 116
R. Scott Mead Australia 5 28 0.7× 14 0.4× 48 1.5× 8 0.2× 5 0.4× 5 91
Sara Duarte Portugal 5 46 1.2× 70 1.8× 14 0.4× 14 0.4× 14 1.2× 10 140
Marten Hansen Netherlands 7 73 1.9× 45 1.2× 10 0.3× 20 0.6× 11 0.9× 10 123
Sarva Keihani Germany 4 142 3.6× 19 0.5× 11 0.3× 9 0.3× 9 0.8× 4 176
Helen X Chen United States 6 68 1.7× 21 0.6× 71 2.2× 7 0.2× 11 0.9× 8 127
Patrick Tivnan United States 2 150 3.8× 35 0.9× 22 0.7× 10 0.3× 8 0.7× 3 183
Tomoya Isobe Japan 6 55 1.4× 15 0.4× 18 0.5× 4 0.1× 6 0.5× 10 90

Countries citing papers authored by Rika Kihara

Since Specialization
Citations

This map shows the geographic impact of Rika Kihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Kihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Kihara more than expected).

Fields of papers citing papers by Rika Kihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika Kihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Kihara. The network helps show where Rika Kihara may publish in the future.

Co-authorship network of co-authors of Rika Kihara

This figure shows the co-authorship network connecting the top 25 collaborators of Rika Kihara. A scholar is included among the top collaborators of Rika Kihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika Kihara. Rika Kihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ushijima, Yoko, Yuichi Ishikawa, Naomi Kawashima, et al.. (2024). Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. Scientific Reports. 14(1). 15906–15906.
2.
Kawashima, Naomi, Yuichi Ishikawa, Yoko Ushijima, et al.. (2022). Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells. Nature Communications. 13(1). 1624–1624. 15 indexed citations
4.
Ishikawa, Yuichi, Naomi Kawashima, Yoko Ushijima, et al.. (2019). Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia. Blood. 134(Supplement_1). 1418–1418. 1 indexed citations
5.
Kihara, Rika, et al.. (2018). Effect of Speciallist Palliative Care Service on End-of Life Care in Patients with Hematologic Malignancies. Blood. 132(Supplement 1). 2242–2242. 1 indexed citations
6.
Itonaga, Hidehiro, Rika Kihara, Yasunobu Nagata, et al.. (2018). Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia. Leukemia Research. 65. 34–41. 5 indexed citations
7.
Chen, Fangli, Yuichi Ishikawa, Rika Kihara, Tomoki Naoe, & Hitoshi Kiyoi. (2015). Mechanism of FLT3 ligand dependent resistance to FLT3 inhibitors. Experimental Hematology. 43(9). S57–S57. 1 indexed citations
8.
Kihara, Rika, et al.. (2014). Legal Aspects of End-of-Life Care in Severe Anorexia Nervosa. 4(1). 1–11.
9.
Kiyoi, Hitoshi, Yuichi Ishikawa, Fumihiko Hayakawa, et al.. (2013). GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation. Leukemia Research Reports. 2(1). 21–25. 9 indexed citations
10.
Kihara, Rika, Tomoyuki Watanabe, Takahiro Yano, et al.. (2012). Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups. International Journal of Hematology. 97(1). 98–102. 6 indexed citations
11.
Tsuboi, Kosuke, Toshiya Yokozawa, Toru Sakura, et al.. (2011). A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia. Leukemia Research. 35(10). 1384–1389. 46 indexed citations
12.
Kihara, Rika, et al.. (2011). DNMT3A and IDH1/2 Mutations Are Stable During the Progression of Acute Myeloid Leukemia. Blood. 118(21). 1466–1466. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026